Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis

Journal of Ocular Pharmacology and Therapeutics

Volumn 24, Issue 2, 2008, Pages 217-223

  Afshari, Natalie A ^a   Ma, Joseph J K ^b   Duncan, Scott M ^a   Pineda, Roberto ^b   Starr, Christopher E ^b   Decroos, Francis Char ^a   Johnson, Carl S ^a   Adelman, Ron A ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CIPROFLOXACIN; GENTAMICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL KERATITIS; EYE DISEASE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; KERATITIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CEFAZOLIN; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; EYE INFECTIONS, BACTERIAL; GENTAMICINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KERATITIS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES;

EID: 41349112800     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2007.0085     Document Type: Article

References (31)

1. McLeod, S.D., Kolahdouz-Isfahani, A., Rostamian, K., et al. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. Ophthalmology 103:23-28, 1996.
2. O'Brien, T.P., Maguire, M.G., Fink, N.E., et al. Efficacy of ofloxacin versus cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch. Ophthalmol. 113:1257-1265, 1995.
3. Rodman, R.C., Spisak, S., Sugar, A., et al. The utility of culturing corneal ulcers in a tertiary referral center versus a general ophthalmology clinic. Ophthalmology 104:1897-1901, 1997.
4. McLeod, S.D., LaBree, L.D., Tayyanipour, R., et al. The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology 102:1943-1948, 1995.
5. Schaefer, F., Bruttin, O., Zografos, L., et al. Bacterial keratitis: A prospective clinical and microbiological study. Br. J. Ophthalmol. 85:842-847, 2001.
6. Bower, K.S., Kowalski, R.P., and Gordon, Y.J. Fluoroquinolones in the treatment of bacterial keratitis. Am. J. Ophthalmol. 121:712-715, 1996.
7. Gangopadhyay, N., Daniell, M., Weih, L., et al. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br. J. Ophthalmol. 84:378-384, 2000.
8. Goldstein, M.H., Kowalski, R.P., and Gordon, Y.J. Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review. Ophthalmology 106:1313-1318, 1999.
9. Hyndiuk, R.A., Eiferman, R.A., Caldwell, D.R., et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology 103:1854-1862; discussion 1862-1853, 1996.
10. Smith, A., Pennefather, P.M., Kaye, S.B., et al. Fluoroquinolones: Place in ocular therapy. Drugs 61:747-761, 2001.
11. Parks, D.J., Abrams, D.A., Sarfarazi, F.A., et al. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am. J. Ophthalmol. 115:471-477, 1993.
12. Garg, P., Sharma, S., and Rao, G.N. Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology 106:1319-1323, 1999.
13. The Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: A double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group. Ophthalmology 104:1902-1909, 1997.
14. Kunimoto, D.Y., Sharma, S., Garg, P., et al. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. Ophthalmology 106:80-85, 1999.
15. Knauf, H.P., Silvany, R., Southern, P.M., Jr., et al. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea 15:66-71, 1996.
16. Snyder, M.E., and Katz, H.R. Ciprofloxacin-resistant bacterial keratitis. Am. J. Ophthalmol. 114:336-338, 1992.
17. Alexandrakis, G., Alfonso, E.C., and Miller, D. Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. Ophthalmology 107:1497-1502, 2000.
18. Guzek, J.P., Chacko, D., Kettering, J.D., et al. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis. Cornea 13:500-504, 1994.
19. Gritz, D.C., and Whitcher, J.P., Jr. Topical issues in the treatment of bacterial keratitis. Int. Ophthalmol. Clin. 38:107-114, 1998.
20. Marangon, F.B., Miller, D., Muallem, M.S., et al. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am. J. Ophthalmol. 137: 453-458, 2004.
21. Schlech, B.A., and Alfonso, E. Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX). Surv. Ophthalmol. 50(Suppl. 1):S7-S15, 2005.
22. Parmar, P., Salman, A., Kalavathy, C.M., et al. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis. Am. J. Ophthalmol. 141:282-286, 2006.
23. Moshirfar, M., Mirzaian, G., Feiz, V., et al. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J. Cataract Refract. Surg. 32: 515-518, 2006.
24. Deramo, V.A., Lai, J.C., Fastenberg, D.M., et al. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. Am. J. Ophthalmol. 142:721-725, 2006.
25. Chalita, M.R., Hofling-Lima, A.L., Paranhos, A., Jr., et al. Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years. Am. J. Ophthalmol. 137:43-51, 2004.
26. Ly, C.N., Pham, J.N., Badenoch, P.R., et al. Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin. Clin. Exp. Ophthalmol. 34:44-50, 2006.
27. Yeh, D.L., Stinnett, S.S., and Afshari, N.A. Analysis of bacterial cultures in infectious keratitis, 1997-2004. Am. J. Ophthalmol. 142:1066-1068, 2006.
28. McDonnell, P.J., Nobe, J., Gauderman, W.J., et al. Community care of corneal ulcers. Am. J. Ophthalmol. 114:531-538, 1992.
29. Callegan, M.C., Engel, L.S., Hill, J.M., et al. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis. Invest. Ophthalmol. Vis. Sci. 35:1033-1037, 1994.
30. Gudmundsson, O.G., Ormerod, L.D., Kenyon, K.R., et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea 8:115-121, 1989.
31. Schlegel, L., Chaumeil, C., Quesnot, S., et al. [Retrospective study of the prevalence and sensitivity to antibiotics of bacteria isolated from ocular samplings]. J. Fr. Ophtalmol. 18:250-258, 1995.